i like cydy to do trials such as nash and alzheime
Post# of 145444
![](/assets/46931549/no_avatar_available_thumb.jpg)
with very little chance of butting heads with big pharma competition wise.plus fda
should look upon cydy very favorably if trial results are strong.my interest is peaked re the kind of alzheimer testing would be done to determine whether a patient is a very early stage candidate and that leronlimab could nip it in the bud? imo
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)